AU2001296029A1 - Pharmaceutical preparation of percutaneous absorption type - Google Patents

Pharmaceutical preparation of percutaneous absorption type

Info

Publication number
AU2001296029A1
AU2001296029A1 AU2001296029A AU9602901A AU2001296029A1 AU 2001296029 A1 AU2001296029 A1 AU 2001296029A1 AU 2001296029 A AU2001296029 A AU 2001296029A AU 9602901 A AU9602901 A AU 9602901A AU 2001296029 A1 AU2001296029 A1 AU 2001296029A1
Authority
AU
Australia
Prior art keywords
pharmaceutical preparation
absorption type
percutaneous absorption
percutaneous
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296029A
Inventor
Kazunosuke Aida
Naruhito Higo
Shuji Sato
Takaaki Terahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of AU2001296029A1 publication Critical patent/AU2001296029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001296029A 2000-11-07 2001-10-30 Pharmaceutical preparation of percutaneous absorption type Abandoned AU2001296029A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-339524 2000-11-07
JP2000339524 2000-11-07
PCT/JP2001/009496 WO2002038139A1 (en) 2000-11-07 2001-10-30 Pharmaceutical preparation of percutaneous absorption type

Publications (1)

Publication Number Publication Date
AU2001296029A1 true AU2001296029A1 (en) 2002-05-21

Family

ID=18814588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296029A Abandoned AU2001296029A1 (en) 2000-11-07 2001-10-30 Pharmaceutical preparation of percutaneous absorption type

Country Status (6)

Country Link
US (1) US20040028724A1 (en)
EP (1) EP1340496A4 (en)
JP (1) JP4057418B2 (en)
AU (1) AU2001296029A1 (en)
CA (1) CA2428181A1 (en)
WO (1) WO2002038139A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
WO2002038139A1 (en) * 2000-11-07 2002-05-16 Hisamitsu Pharmaceutical Co., Inc. Pharmaceutical preparation of percutaneous absorption type
US7988991B2 (en) * 2001-03-07 2011-08-02 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
JP4354678B2 (en) * 2002-08-28 2009-10-28 久光製薬株式会社 Patch
JP4792193B2 (en) * 2002-08-28 2011-10-12 久光製薬株式会社 Patch
JP4213432B2 (en) * 2002-08-28 2009-01-21 久光製薬株式会社 Patch
US20070073338A1 (en) * 2003-09-04 2007-03-29 Roy Raghunandan Supercutaneous method and device for promoting hemostasis in cannulated patient
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
US20080038328A1 (en) * 2004-05-28 2008-02-14 Naruhito Higo Pasting Preparation
WO2005117886A1 (en) * 2004-06-01 2005-12-15 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
DE602005020393D1 (en) * 2004-06-01 2010-05-20 Hisamitsu Pharmaceutical Co Adhesive plaster
JP4986411B2 (en) * 2004-06-01 2012-07-25 久光製薬株式会社 Patch
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
JP5084496B2 (en) * 2005-02-04 2012-11-28 久光製薬株式会社 Transdermal patch
WO2006093139A1 (en) 2005-02-28 2006-09-08 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5122445B2 (en) 2006-05-08 2013-01-16 帝國製薬株式会社 Transdermal absorption preparation of antidementia drug
US8580281B2 (en) 2008-02-27 2013-11-12 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
ES2661767T3 (en) 2008-02-27 2018-04-03 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
US20110189261A1 (en) * 2008-03-03 2011-08-04 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5368168B2 (en) * 2008-06-16 2013-12-18 日東電工株式会社 Patches and patch preparations
ITMI20081652A1 (en) * 2008-09-16 2010-03-17 Antica Ritrovati Medicinal I S A R M Srl Soc TRANSDERMIC COMPOSITIONS FOR HYPOSENSIBILIZING SPECIFIC IMMUNOTHERAPY
CN105419206B (en) * 2009-07-30 2017-12-15 赢创罗姆有限公司 Powdered or granular composition comprising copolymer, dicarboxylic acids and aliphatic mono-carboxylic acids
WO2011012161A1 (en) 2009-07-30 2011-02-03 Evonik Röhm Gmbh Powdery or granulated composition comprising a copolymer, a dicarboxylic acid and a fatty monocarboxylic acid
EP2514414A4 (en) * 2009-12-16 2013-05-29 Goto Takeshi Transdermally absorbed preparation of anti-dementia drug
WO2011074637A1 (en) 2009-12-16 2011-06-23 後藤 武 Transdermally absorbed preparation of anti-dementia drug
JP2012236773A (en) * 2009-12-16 2012-12-06 Goto Takeshi Transdermally absorbable preparation of anti-dementia drug
JP5631854B2 (en) * 2010-12-13 2014-11-26 久光製薬株式会社 Pharmaceutical composition and patch
JP5906302B2 (en) 2011-03-24 2016-04-20 テイコク ファーマ ユーエスエー インコーポレーテッド Transdermal composition comprising an agent layer and an agent conversion layer
KR101856515B1 (en) 2012-11-02 2018-05-10 테이코쿠 팔마 유에스에이, 인코포레이티드 Propynylaminoindan transdermal compositions
US9980920B2 (en) 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent
JPWO2017094337A1 (en) * 2015-12-04 2018-09-20 ニチバン株式会社 Patch
US9993466B2 (en) * 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
EP3818982B1 (en) * 2018-01-31 2023-12-20 Medrx Co., Ltd. Tizanidine therapy system

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
DE3581428D1 (en) * 1984-06-13 1991-02-28 Roehm Gmbh METHOD FOR COVERING MEDICINAL FORMS.
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE69009540T2 (en) * 1989-03-15 1994-09-29 Nitto Denko Corp Adhesive plasters containing medicines.
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
JP2977254B2 (en) 1990-09-04 1999-11-15 積水化学工業株式会社 Transdermal patch
JP3253431B2 (en) * 1993-09-29 2002-02-04 積水化学工業株式会社 Medical patch
JP3908795B2 (en) * 1994-11-29 2007-04-25 久光製薬株式会社 Ketotifen-containing transdermal preparation
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
AU4320997A (en) * 1996-09-26 1998-04-17 Hokuriku Seiyaku Co. Ltd Percutaneous preparations
DE19653606A1 (en) * 1996-12-20 1998-06-25 Roehm Gmbh Adhesive and binder made from (meth) acrylate polymer, organic acid and plasticizer
JPH1112177A (en) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd Stable aspirin-containing preparation for external use
JP4205778B2 (en) * 1998-04-17 2009-01-07 久光製薬株式会社 Patch preparation
JP4275768B2 (en) 1998-06-18 2009-06-10 久光製薬株式会社 Aqueous adhesive paste
IT1317736B1 (en) * 2000-01-26 2003-07-15 A C R Applied Coating Res S A PATCH FOR LOCAL AND TRANSDERMAL ADMINISTRATION OF PRINCIPIACTIVES EQUIPPED WITH ANIONIC GROUPS AND ELECTRONATTRACTORS.
WO2002038139A1 (en) * 2000-11-07 2002-05-16 Hisamitsu Pharmaceutical Co., Inc. Pharmaceutical preparation of percutaneous absorption type

Also Published As

Publication number Publication date
JP4057418B2 (en) 2008-03-05
JPWO2002038139A1 (en) 2004-03-11
EP1340496A1 (en) 2003-09-03
WO2002038139A1 (en) 2002-05-16
EP1340496A4 (en) 2004-04-14
CA2428181A1 (en) 2002-05-16
US20040028724A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
AU2001296029A1 (en) Pharmaceutical preparation of percutaneous absorption type
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2002225855A1 (en) Preparation of nanocrystallites
DZ3311A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
DZ3313A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2002221115A1 (en) Medicinal compositions having improved absorbability
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001273919A1 (en) Pharmaceutical compositions
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001284763A1 (en) Preparation of risperidone
AU4085201A (en) Pharmaceutical composition
AU2001292578A1 (en) Pharmaceutical compounds
AU2001250625A1 (en) 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AU2001292001A1 (en) Pharmaceutical oxan preparation
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application